Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Lilly To Open Cambridge Hub
by Lisa M. Jarvis
May 11, 2015
| A version of this story appeared in
Volume 93, Issue 19
Eli Lilly & Co. is joining the rest of its big pharma competitors by establishing a presence in Cambridge, Mass. Looking to capitalize on the vast academic and biotech talent in the area, the Indianapolis-based firm will open a drug delivery and device innovation center in Kendall Square. Lilly has already begun building the labs, which will increase its delivery and device R&D space by almost 50% when they open at the end of the year. Some 30 scientists and engineers will be hired over the next two years for the Cambridge site.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X